What is a stock summary page? Click here for an overview.
Business Description
Adicet Bio Inc
NAICS : 541714
SIC : 2834
ISIN : US0070021086
Share Class Description:
LTS:0HX7: Ordinary SharesDescription
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.23 | |||||
| Equity-to-Asset | 0.85 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.16 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 13.6 | |||||
| 3-Year EPS without NRI Growth Rate | 12.7 | |||||
| 3-Year FCF Growth Rate | 19.9 | |||||
| 3-Year Book Growth Rate | -33.3 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 16.53 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 6.88 | |||||
| 9-Day RSI | 16.85 | |||||
| 14-Day RSI | 24.22 | |||||
| 3-1 Month Momentum % | -15.92 | |||||
| 6-1 Month Momentum % | -43.55 | |||||
| 12-1 Month Momentum % | -63.2 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 9.29 | |||||
| Quick Ratio | 9.29 | |||||
| Cash Ratio | 9.09 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.6 | |||||
| Shareholder Yield % | -204.7 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -55.13 | |||||
| ROA % | -47.4 | |||||
| ROIC % | -252.29 | |||||
| 3-Year ROIIC % | 400.27 | |||||
| ROC (Joel Greenblatt) % | -289.84 | |||||
| ROCE % | -51.28 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.23 | |||||
| Price-to-Tangible-Book | 0.23 | |||||
| EV-to-EBIT | 0.99 | |||||
| EV-to-EBITDA | 1.04 | |||||
| EV-to-FCF | 1.14 | |||||
| Price-to-GF-Value | 2.05 | |||||
| Price-to-Net-Current-Asset-Value | 0.29 | |||||
| Price-to-Net-Cash | 0.3 | |||||
| Earnings Yield (Greenblatt) % | 100.95 | |||||
| FCF Yield % | -217.45 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adicet Bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.34 | ||
| Beta | 0.92 | ||
| 3-Year Sharpe Ratio | -0.81 | ||
| 3-Year Sortino Ratio | -1.06 | ||
| Volatility % | 43.97 | ||
| 14-Day RSI | 24.22 | ||
| 14-Day ATR ($) | 0.045247 | ||
| 20-Day SMA ($) | 0.769045 | ||
| 12-1 Month Momentum % | -63.2 | ||
| 52-Week Range ($) | 0.5543 - 2.345 | ||
| Shares Outstanding (Mil) | 82.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Adicet Bio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Adicet Bio Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Adicet Bio Inc Frequently Asked Questions
What is Adicet Bio Inc(LTS:0HX7)'s stock price today?
The current price of LTS:0HX7 is $0.55. The 52 week high of LTS:0HX7 is $2.35 and 52 week low is $0.55.
When is next earnings date of Adicet Bio Inc(LTS:0HX7)?
The next earnings date of Adicet Bio Inc(LTS:0HX7) is 2025-05-14 Est..
Does Adicet Bio Inc(LTS:0HX7) pay dividends? If so, how much?
Adicet Bio Inc(LTS:0HX7) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers